Northern Trust Corp Has $52.46 Million Holdings in Maximus, Inc. $MMS

Key Points

• Northern Trust Corp has reduced its holdings in Maximus, Inc. by 5.6%, selling 45,773 shares, leaving them with approximately 769,360 shares valued at $52.46 million.
• Multiple institutional investors, including Caitong International Asset Management and UMB Bank, significantly increased their stakes in Maximus during the first quarter.
• Maximus recently reported a quarterly earnings per share (EPS) of $2.16, exceeding expectations, and has declared a quarterly dividend of $0.30 per share.

Northern Trust Corp lessened its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 5.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 769,360 shares of the health services provider's stock after selling 45,773 shares during the period. Northern Trust Corp owned 1.36% of Maximus worth $52,463,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Captrust Financial Advisors acquired a new position in Maximus during the fourth quarter valued at approximately $276,000. GAMMA Investing LLC grew its holdings in Maximus by 67.1% during the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock valued at $50,000 after purchasing an additional 294 shares during the last quarter. Blue Trust Inc. grew its holdings in Maximus by 32.8% during the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock valued at $84,000 after purchasing an additional 303 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Maximus during the first quarter valued at approximately $2,115,000. Finally, Janney Montgomery Scott LLC grew its holdings in Maximus by 70.5% during the first quarter. Janney Montgomery Scott LLC now owns 10,145 shares of the health services provider's stock valued at $692,000 after purchasing an additional 4,196 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.

Maximus Stock Performance

Shares of NYSE:MMS traded up $0.34 during trading on Friday, hitting $88.06. 434,573 shares of the stock were exchanged, compared to its average volume of 681,324. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.94. The company has a market capitalization of $4.96 billion, a price-to-earnings ratio of 16.22 and a beta of 0.60. The company's fifty day simple moving average is $76.35 and its 200-day simple moving average is $71.67. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.77. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same quarter last year, the firm earned $1.74 EPS. Maximus's revenue for the quarter was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Sell-side analysts expect that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, August 15th. Maximus's dividend payout ratio (DPR) is presently 22.10%.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on MMS. Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th. Zacks Research upgraded Maximus from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Strong Buy" and a consensus price target of $90.00.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.